EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Given Average Recommendation of “Buy” by Analysts

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) has earned a consensus rating of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have given a buy recommendation and two have assigned a strong buy recommendation to the company.

ESLOY has been the topic of several research analyst reports. Citigroup reaffirmed a “buy” rating on shares of EssilorLuxottica in a research note on Thursday, December 11th. The Goldman Sachs Group reissued a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. Finally, HSBC raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th.

Check Out Our Latest Report on EssilorLuxottica

EssilorLuxottica Trading Down 0.1%

Shares of ESLOY opened at $111.43 on Friday. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. EssilorLuxottica has a 52-week low of $110.41 and a 52-week high of $186.81. The business’s fifty day moving average is $137.28 and its 200-day moving average is $157.88.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Articles

Analyst Recommendations for EssilorLuxottica (OTCMKTS:ESLOY)

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.